Abstract
Hepatic distribution and elimination of terbutaline sulfate (TBS) was investigated in the in situ isolated perfused rat liver preparation. Perfusion experiments were conducted using Krebs bicarbonate buffer delivered via the portal vein in a single-pass mode at a total flow rate of 15 mL min−1. TBS was administered as a bolus (2 mg mL−1) in the absence and presence of erythrocytes (50% hematocrit) or albumin (1%). Immediately after a bolus administration, the outflow perfusate was collected and then concentration of TBS was determined by a validated HPLC method. Regardless of the condition, the extraction of TBS (0.35–0.51) across the liver during single pass was intermediate. Although protein binding of TBS was very low (2.5%), it was taken up slowly and continuously by erythrocytes. A blood to plasma concentration ratio of 2.8 obtained at the end of incubation period clearly indicates that TBS has an affinity to erythrocytes. However, under the conditions used in this study, hepatic distribution and elimination of TBS were not influenced by the presence of erythrocytes or albumin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bergman B, Bokstrom H, Borga O, Enk L, Hedner T, Wangberg B (1984) Transfer of terbutaline across the human placenta in late pregnancy. Eur J Respir Dis 65(Suppl. 134):81–86
Borga O, Lindberg C (1984) Pharmacokinetic implications of slow equilibration of terbutaline between plasma and erythrocytes. Eur J Respir Dis 65(Suppl. 134):73–80
Borgstrom L, Nyberg L, Jonsson S, Lindberg C, Paulson J (1989) Pharmacokinetic evaluation in man of terbutaline given as separate enantiomers and as the racemate. Br J Clin Pharmacol 27:49–56
Chiou WL (1984) A new model-independent physiological approach to study hepatic drug clearance and its applications. Int J Clin Pharmacol Ther Toxicol 22:577–590
Davies DS (1984) Pharmacokinetics of terbutaline after oral administration. Eur J Respir Dis 65(Supp1. 134):111–117
Fagerholm U, Borgstrom L, Ahrenstedt O, Lennernas H (1995) The lack of effect of induced net fluid absorption on the in vivo permeability of terbutaline in the human jejunum. J Drug Target 3(3):191–200
Goresky CA, Bach GG, Simard A, Schwab AJ, Bracht A (2000) Uptake of lactate by the liver: effect of red blood cell carriage. Am J Physiol Gastrointest Liver Physiol 278(5):G775–G788
Heatherington AC (1994) A physiologic based pharmacokinetic model for drug distribution. PhD Thesis, University of Manchester, UK
Hultquist C, Lindberg C, Nyberg L, Kjellman B, Wettrell G (1989) Pharmacokinetics of intravenous terbutaline in asthmatic children. Dev Pharmacol Ther 13(1):11–20
Karabey Y, Sahin S (2006a) Human erythrocytes are not suitable for determination of intravascular volume of perfused rat liver. Methods Find Exp Clin Pharmacol 28(6):355–359
Karabey Y, Sahin S (2006b) Estimation of hepatic distributional volumes using non-labeled reference markers. Eur J Drug Metab Pharmacokinet 31(4):285–290
Lee HJ, Chiou WL (1989a) Erythrocytes as barriers for drug elimination in the isolated rat liver. I Doxorubicin. Pharm Res 6(10):833–838
Lee HJ, Chiou WL (1989b) Erythrocytes as barriers for drug elimination in the isolated rat liver. II Propranolol. Pharm Res 6(10):840–843
Nilsson HT, Persson CG, Persson K, Tegner K, Ryrfeldt A (1973) The metabolism of terbutaline in dog and rat. Xenobiotica 3(9):615–623
Nyberg L (1984) Pharmacokinetic parameters of terbutaline in healthy man: an overview. Eur J Respir Dis 65(Suppl. 134):149–160
Nyberg L, Kennedy BM (1984) Pharmacokinetics of terbutaline given in slow-release tablets. Eur J Respir Dis 65(Supp1 134):119–139
Pacifici GM, Eligi M, Giulliani L (1993) (+) and (−) Terbutaline are sulphated at a higher rate in human intestine than in liver. Eur J Clin Pharmacol 45:483–487
Rowland M, Tozer TN (1995) Clinical pharmacokinetics: concepts and applications, 3rd edn. Lea & Febiger, Philadelphia, p 123
Ryrfeldt A, Ramsay CH (1984) Distribution of terbutaline. Eur J Respir Dis 65(Suppl. 134):63–72
Sahin S, Rowland M (1998) Development of an optimal method for the dual perfusion of the isolated rat liver. J Pharmacol Toxicol Methods 39(1):35–43
Sahin S, Rowland M (2000) Estimation of aqueous distributional spaces in the dual perfused rat liver. J Physiol (Lond) 528(1):199–207
Sahin S, Rowland M (2007) Influence of erythrocytes on the hepatic distribution kinetics of urea and thiourea. Eur J Pharm Sci 31(3–4):180–189
Sahin S, Selek H, Ponchel G, Ercan MT, Sargon M, Hincal AA, Kas HS (2002) Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres. J Control Release 82(2–3):345–358
Sweetman SC (2002) Martindale, the complete drug reference, 33rd edn. The Pharmaceutical Press, London
Tanaka S, Momose Y, Tsutsui M, Kishida T, Kuroda J, Shibata N, Yoshida T, Yamagishi R (2004) Quantitative estimation of myocardial fibrosis based on receptor occupancy for β2-adrenergic receptor agonists in rats. J Toxicol Sci 29(3):179–186
Tegner K, Nilsson HT, Persson CG, Persson K, Ryrfeldt A (1984) Elimination pathways of terbutaline. Eur J Respir Dis 65(Suppl. 134):93–100
Wang Z, Zhang Z, Fu Z, Chen D, Zhang X (2003) Flow-injection chemiluminescence detection for studying protein binding of terbutaline sulfate with on-line microdialysis sampling. J Pharm Biomed Anal 33(4):765–773
Acknowledgments
This study was supported by a research Grant from Hacettepe University (Project No: 0201301002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sahin, S., Karabey, Y. Investigation of distribution and elimination of terbutaline sulfate in the perfused rat liver preparation. Eur J Drug Metab Pharmacokinet 35, 9–14 (2010). https://doi.org/10.1007/s13318-010-0002-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13318-010-0002-0